Donate

janssen research

Home»Posts tagged with»janssen research

Ulcerative Colitis J&J seeks approval Simponi

Ulcerative Colitis J&J seeks approval Simponi A subsidiary of Johnson & Johnson is hoping to win an additional approval for one of its drugs. Janssen Biotech and Janssen Biologics B.V. announced the submission of a supplemental regulatory application to the Food and Drug Administration for Simponi (golimumab) for treatment of moderately to severely active ulcerative […]

Phase 3 Study Results Show Anti-TNF SIMPONI® Active Ulcerative Colitis

Phase 3 Study Results Show Anti-TNF SIMPONI® Active Ulcerative Colitis

Phase 3 Study Results Show Anti-TNF SIMPONI® Induced Clinical Response in Adults With Moderately to Severely Active Ulcerative Colitis   First Presentation of Phase 3 Data Shows Significant Improvements in Clinical Remission, Mucosal Healing and Quality of Life Measures after SIMPONI Induction Treatment New study findings show that subcutaneous induction regimens of the anti-tumor necrosis […]

No Guts Know Glory

IDEAS Kids

IDEAS Kids

IBD Adventures